GeneDx Holdings
58 hedge funds and large institutions have $127M invested in GeneDx Holdings in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 9 closing their positions.
271% more capital invested
Capital invested by funds: $34.2M → $127M (+$92.8M)
111% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 9
100% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 8
21% more funds holding
Funds holding: 48 → 58 (+10)
5.32% more ownership
Funds ownership: 48.07% → 53.39% (+5.3%)
43% less call options, than puts
Call options by funds: $234K | Put options by funds: $414K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$5.69M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$4.34M |
| 3 |
GS
Gagnon Securities
New York
|
+$1.24M |
| 4 |
GA
Gagnon Advisors
New York
|
+$373K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$332K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$3.37M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$670K |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
-$175K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$168K |
| 5 |
Pathstone Holdings
Englewood,
New Jersey
|
-$158K |
WGS Hedge Fund Activity: Q1 2024 in Review
58 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q1 2024, worth a combined $127M — up 271% from $34.2M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new WGS positions and 9 closed out — a net gain of 10 holders — while 16 added to existing stakes and 8 trimmed.
The largest buyer was Oracle Investment Management, adding an estimated $5.69M. The largest seller was Goldman Sachs, cutting an estimated $3.37M.
- 58 institutional investors held GeneDx Holdings (WGS) as of Q1 2024, up from 48 in Q4 2023.
- Funds reported $127M of GeneDx Holdings stock for Q1 2024, up 271% quarter-over-quarter.
- 19 funds opened new GeneDx Holdings positions in Q1 2024 and 9 closed out, a net change of +10 holders.
- The largest GeneDx Holdings buyer in Q1 2024 was Oracle Investment Management, an estimated $5.69M added.
- The largest GeneDx Holdings seller in Q1 2024 was Goldman Sachs, an estimated $3.37M sold.
Based on aggregated 13F filings for Q1 2024.